CFM
BNTX icon

Comprehensive Financial Management’s BioNTech BNTX Stock Holding History

Comprehensive Financial Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,100
Closed -$262K – 47
2023
Q1 		$262K Hold
2,100
– – 0.01% 44
2022
Q4 		$315K Hold
2,100
– – 0.01% 43
2022
Q3 		$283K Hold
2,100
– – 0.01% 44
2022
Q2 		$313K Hold
2,100
– – 0.01% 44
2022
Q1 		$358K Hold
2,100
– – 0.01% 44
2021
Q4 		$541K Sell
2,100
-200
-9% -$54.8K 0.01% 45
2021
Q3 		$628K Buy
2,300
+1,100
+92% +$350K 0.01% 37
2021
Q2 		$269K Buy
+1,200
New +$226K ﹤0.01% 41

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Comprehensive Financial Management's BNTX Position: Q2 2023 in Review

Comprehensive Financial Management sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 2,100 shares — an estimated $262K sold.

Comprehensive Financial Management first reported a position in BNTX in Q2 2021 and held it in 8 quarters. The position peaked at $628K in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Comprehensive Financial Management reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Comprehensive Financial Management sold 2,100 BioNTech shares in Q2 2023, an estimated $262K.
  • Comprehensive Financial Management first reported a position in BioNTech in Q2 2021 and held it in 8 quarters.
  • Comprehensive Financial Management's BioNTech position peaked at $628K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Comprehensive Financial Management's 13F filing for Q2 2023, filed 14 Aug 2023.